![PDF) Corrigendum to “Structure-based design and synthesis of macrocyclic peptidomimetic β-secretase (BACE-1) inhibitors” [Bioorg. Med. Chem. Lett. 19 (2009) 1361–1365] | Ulf Neumann - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/43610754/mini_magick20190215-24458-m15ml6.png?1550286693 "PDF) Corrigendum to “Structure-based design and synthesis of macrocyclic peptidomimetic β-secretase (BACE-1) inhibitors” [Bioorg. Med. Chem. Lett. 19 (2009) 1361–1365] | Ulf Neumann - Academia.edu")
PDF) Corrigendum to “Structure-based design and synthesis of macrocyclic peptidomimetic β-secretase (BACE-1) inhibitors” [Bioorg. Med. Chem. Lett. 19 (2009) 1361–1365] | Ulf Neumann - Academia.edu
Bioorganic & Medicinal Chemistry Letters | Vol 25, Issue 1, Pages 1-152 (1 January 2015) | ScienceDirect.com by Elsevier
Bioorganic & Medicinal Chemistry template - For Authors
Bioorganic & Medicinal Chemistry Letters | Vol 28, Issue 2, Pages 53-230 (15 January 2018) | ScienceDirect.com by Elsevier
![PDF) Corrigendum to “Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides” [Bioorg. Med. Chem. Lett. 26 (2016) 5867–5870]](https://i1.rgstatic.net/publication/318331613_Corrigendum_to_Synthesis_and_carbonic_anhydrase_inhibitory_properties_of_novel_chalcone_substituted_benzenesulfonamides_Bioorg_Med_Chem_Lett_26_2016_5867-5870/links/5e28005b92851c3aadcfb95e/largepreview.png "PDF) Corrigendum to “Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides” [Bioorg. Med. Chem. Lett. 26 (2016) 5867–5870]")
PDF) Corrigendum to “Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides” [Bioorg. Med. Chem. Lett. 26 (2016) 5867–5870]
Bioorganic & Medicinal Chemistry Letters XXX (2011) XXX-XXX | PDF | Molecules | Chemical Bond
![PDF) Corrigendum to 'Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA' [Bioor. Med. Chem. Lett. 29/10 (2019) 1246–1255]](https://i1.rgstatic.net/publication/332830620_Corrigendum_to_'Synthesis_and_biological_evaluation_of_Doxorubicin-containing_conjugate_targeting_PSMA'_Bioor_Med_Chem_Lett_2910_2019_1246-1255/links/60084c9192851c13fe2413ca/largepreview.png "PDF) Corrigendum to 'Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA' [Bioor. Med. Chem. Lett. 29/10 (2019) 1246–1255]")
PDF) Corrigendum to 'Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA' [Bioor. Med. Chem. Lett. 29/10 (2019) 1246–1255]
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry
Corrigendum to “Novel purine-based fluoroaryl-1,2,3-triazoles as neuroprotecting agents: Synthesis, neuronal cell culture
![PDF) Erratum to “Inhibitors of potassium channels KV1.3 and IK-1 as immunosuppressants” [Bioorg. Med. Chem. Lett. 19 (2009) 2299–2304] | Stephan Grissmer - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/42665312/mini_magick20190217-8886-1ojl54i.png?1550420382 "PDF) Erratum to “Inhibitors of potassium channels KV1.3 and IK-1 as immunosuppressants” [Bioorg. Med. Chem. Lett. 19 (2009) 2299–2304] | Stephan Grissmer - Academia.edu")
PDF) Erratum to “Inhibitors of potassium channels KV1.3 and IK-1 as immunosuppressants” [Bioorg. Med. Chem. Lett. 19 (2009) 2299–2304] | Stephan Grissmer - Academia.edu
Fragment-to-Lead Medicinal Chemistry Publications in 2017 | Journal of Medicinal Chemistry
Bioorganic and Medicinal Chemistry Letters | Scholars Portal Journals
Bioorganic & Medicinal Chemistry Letters | Vol 52, 15 November 2021 | ScienceDirect.com by Elsevier
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry
Bioorganic & Medicinal Chemistry Letters | Vol 30, Issue 17, 1 September 2020 | ScienceDirect.com by Elsevier
![PDF) Corrigendum to "A cascade synthesis, in vitro cholinesterases inhibitory activity and docking studies of novel Tacrine-pyranopyrazole derivatives" [Bioorg. Med. Chem. Lett. 28 (14) (2018) 2481-2484] | Raouf Boulcina - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/86158432/mini_magick20220524-9751-1frme9j.png?1653401507 "PDF) Corrigendum to \"A cascade synthesis, in vitro cholinesterases inhibitory activity and docking studies of novel Tacrine-pyranopyrazole derivatives\" [Bioorg. Med. Chem. Lett. 28 (14) (2018) 2481-2484] | Raouf Boulcina - Academia.edu")
PDF) Corrigendum to "A cascade synthesis, in vitro cholinesterases inhibitory activity and docking studies of novel Tacrine-pyranopyrazole derivatives" [Bioorg. Med. Chem. Lett. 28 (14) (2018) 2481-2484] | Raouf Boulcina - Academia.edu
Bioorganic & Medicinal Chemistry Letters | Vol 33, 1 February 2021 | ScienceDirect.com by Elsevier
Bioorganic & Medicinal Chemistry Letters | Vol 21, Issue 21, Pages 6207-6614 (1 November 2011) | ScienceDirect.com by Elsevier
![PDF) Corrigendum to “2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists” [Bioorg. Med. Chem. Lett. 18 (2008) 2103–2108] | Dale Rudolph - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/47033617/mini_magick20190208-16001-acsyt1.png?1549613596 "PDF) Corrigendum to “2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists” [Bioorg. Med. Chem. Lett. 18 (2008) 2103–2108] | Dale Rudolph - Academia.edu")
PDF) Corrigendum to “2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists” [Bioorg. Med. Chem. Lett. 18 (2008) 2103–2108] | Dale Rudolph - Academia.edu
This article was originally published in a journal published by Elsevier, and the attached copy is provided by Elsevier for the
